Abstract
I suspect that the main reason I was invited to contribute to this symposium was that the organizers believed it would be important to discuss the topic suggested by the title they assigned to me. They were aware that I have been an outspoken critic of the idea that data bases and historical control groups can be used reliably to compare treatments. Since I have already presented my ideas in writing several times, I will merely summarize them briefly here and refer interested readers to the list of references at the end of the contribution, where my previous papers as well as those of some other authors are listed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Byar DP (1979) The necessity and justification of randomized clinical trials. In: Tagnon HJ, Staquet MJ (eds) Controversies in cancer: design of trials and treatment. Masson, New York, pp 75–82
Byar DP (1980) Why data bases should not replace randomized clinical trials. Biometrics 36:337–342
Byar DP (1981) Possibilities and limitations of observational studies and evaluation of medical data bases. In: Victor N, Dudeck J, Broszia EP (eds) Therapiestudien. Proceedings of the 26th annual meeting of the German Society of Medical Documentation, Computer Sciences, and Statistics. Springer, Berlin Heidelberg New York, pp 528–537 (Medizinische Informatik und Statistik, vol 33)
Byar DP, Simon RM, Friedewald WT, Schlesselman JJ, DeMets DK, Ellenberg JH, Gail MH, Ware JH (1976) Randomized clinical trials: perspectives on some recent ideas. N Engl J Med 295: 74–80
Fleming TR (1982) Historical controls, data banks and randomized trials in clinical research: a review. Cancer Treat Rep 66: 1101–1105
Gehan EA, Freireich EJ (1974) Non-randomized controls in cancer clinical trials. N Engl J Med 290: 198–203
Green SB, Byar DP (1984) Using observational data from registries to compare treatments: the fallacy of omnimetrics. Stat Med 3: 361–370
Horwitz RI, Feinstein AR (1981 a) The application of therapeutic-trial principles to improve the design of epidemiologic research: a case-control study suggesting that anticoagulants reduce mortality in patients with myocardial infarction. J Chronic Dis 34: 575–583
Horwitz RI, Feinstein AR (1981 b) Improved observational method for studying therapeutic efficacy: suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarction. JAMA 246: 2455–2459
Mantel N (1983) Cautions on the use of medical data bases. Stat Med 2: 355–362
Rockette HE, Redmond CK, Fisher B, Participating NSABP Investigators (1982) Impact of randomized clinical trials on therapy of primary breast cancer: the NSABP overview. Controlled Clin Trials 3: 209–225
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Byar, D.P. (1988). The Use of Data Bases and Historical Controls in Treatment Comparisons. In: Scheurlen, H., Kay, R., Baum, M. (eds) Cancer Clinical Trials. Recent Results in Cancer Research, vol 111. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83419-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-83419-6_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83421-9
Online ISBN: 978-3-642-83419-6
eBook Packages: Springer Book Archive